Results 31 to 40 of about 9,354,751 (270)

The Diagnostic and Clinical Utility of Autoantibodies in Systemic Vasculitis

Antibodies, 2019
Considerable progress has been made in understanding the role of autoantibodies in systemic vasculitides (SV), and consequently testing for anti-neutrophil cytoplasmic antibodies (ANCA), anti-glomerular basement membrane antibodies (anti-GBM), and anti ...
Elena Csernok
doaj   +1 more source

Checkpoint inhibitor-related renal vasculitis and use of rituximab

Journal for ImmunoTherapy of Cancer, 2020
The percentage of patients with cancer eligible for checkpoint inhibitor (CPI) therapy has increased rapidly over the past few years and approaches 45%.
Noha Abdel-Wahab, Ala Abudayyeh, Omar Mamlouk, Umut Selamet, Jamie S Lin, Maryam Buni, Amanda S Tchakarov   +6 more
doaj   +1 more source

ANCA Associated Vasculitis Treated with Ultra-low Dose Rituximab: A Case Report

Xiehe Yixue Zazhi, 2023
We reported a case of ANCA-associated vasculitis with pulmonary and renal involvement that was effectively treated with glucocorticoids, cyclophosphamide, and plasma exchange therapy.
WU Haiting, LI Hang
doaj   +1 more source

EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis

Annals of the Rheumatic Diseases, 2016
In this article, the 2009 European League Against Rheumatism (EULAR) recommendations for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) have been updated.
M. Yates, R. Watts, I. Bajema, M. Cid, B. Crestani, T. Hauser, B. Hellmich, J. Holle, M. Laudien, M. Little, R. Luqmani, A. Mahr, P. Merkel, J. Mills, J. Mooney, M. Segelmark, V. Tesar, K. Westman, A. Vaglio, N. Yalçındağ, D. Jayne, C. Mukhtyar   +21 more
semanticscholar   +1 more source

ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine

American Journal of Kidney Diseases, 2021
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread around the world. As of the end of June 2021, there were approximately 181 million confirmed cases and more than 3.9 million deaths across the globe.
M. Shakoor, M. Birkenbach, M. Lynch
semanticscholar   +1 more source

Management of ANCA-associated vasculitis: Current trends and future prospects [PDF]

, 2010
Sally Hamour, Alan D Salama, Charles D PuseyImperial College Kidney and Transplant Institute, Imperial College, London, UKAbstract: The antineutrophil cytoplasm antibody (ANCA)-associated vasculitides are a spectrum of heterogeneous autoimmune diseases ...
Hamour, S, Alan D Salama, Pusey, CD, Sally Hamour, Salama, AD, Charles D Pusey, null Hamour, null Salama, Charles Pusey   +8 more
core   +1 more source

Risk factors for serious infections in ANCA-associated vasculitis

Annals of the Rheumatic Diseases, 2023
Objectives Severe infections contribute to morbidity and mortality in antineutrophil cytoplasm antibody-associated vasculitis (AAV). This study aimed to identify risk factors associated with severe infections in participants of the Rituximab versus ...
Balazs Odler, Regina Riedl, P. Gauckler, J. Shin, Johannes Leierer, P. Merkel, W. St Clair, F. Fervenza, Duvuru Geetha, P. Monach, D. Jayne, Rona M. Smith, A. Rosenkranz, U. Specks, J. Stone, A. Kronbichler   +15 more
semanticscholar   +1 more source

Comorbidities in ANCA-associated vasculitis [PDF]

Rheumatology, 2020
Abstract The prognosis of patients with ANCA-associated vasculitis has improved over the past decades, but overall survival rates are still unsatisfactory. Recent research has focused on complications of immunosuppressive measures and comorbidities of ANCA-associated vasculitis.
Jae Il Shin, Philipp Gauckler, Johannes Leierer, Andreas Kronbichler   +3 more
openaire   +3 more sources

ANCA-associated vasculitis after COVID-19

Rheumatology International, 2021
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) are systemic autoimmune diseases that may lead to renal failure due to the infiltration of mononuclear cells and the destruction of small- and medium-sized blood vessels.
Tuğba İzci Duran, E. Turkmen, M. Dilek, Hayriye Sayarlioglu, N. Arik   +4 more
semanticscholar   +1 more source

High anti-neutrophil cytoplasmic antibody titers are associated with the requirement of permanent dialysis in patients with myeloperoxidase-ANCA-associated vasculitis

Journal of the Formosan Medical Association, 2019
Background/Purpose: A reliable noninvasive prognostic factor of ANCA-associated vasculitis (AAV) is still lacking, but little research has focused on the value of MPO-ANCA titers in patients with active vasculitis.
Chieh-Li Yen, Ya-Chung Tian, Hsin-Hsu Wu, Kun-Hua Tu, Shou-Hsuan Liu, Cheng-Chia Lee, Ji-Tseng Fang, Chih-Wei Yang, Yi-Jung Li   +8 more
doaj   +1 more source